Vaxcyte Inc holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 2,155,137 | $81,377,973 | 0.40% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 9, 2025 |
| June 30, 2025 | 3,068,898 | $99,769,874 | 0.42% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 12, 2025 |
| Sept. 30, 2025 | 3,732,715 | $134,452,394 | 0.56% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 12, 2025 |
| Dec. 31, 2025 | 3,539,717 | $163,322,542 | 0.68% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 11, 2026 |
| March 31, 2026 | 3,646,138 | $211,877,079 | 0.89% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 11, 2026 |
| June 30, 2026 | 2,472,428 | $143,722,240 | 0.47% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 12, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.